Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multi-center, Randomized, Double-blind, Placebo-controlled Study, to Evaluate the Safety and Efficacy of SB-01 For Injection for the Treatment of Lumbar Degenerative Disc Disease

NCT05516992 is registered in ClinicalTrials.gov with Spine BioPharma, Inc as lead sponsor.

NCT NCT05516992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05516992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multi-center, Randomized, Double-blind, Placebo-controlled Study, to Evaluate the Safety and Efficacy of SB-01 For Injection for the Treatment of Lumbar Degenerative Disc Disease
Lead sponsor
Spine BioPharma, Inc
Phase
Phase 3
Overall status
Active, not recruiting
Start date
August 19, 2022
Completion date
August 27, 2025
Enrollment
417 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

lumbar degenerative disc disease